BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4040729)

  • 1. [Prostatic osteocondensing metastases. The value of examining for osteomalacia].
    Mage P; Coindre JM; Goussot JF; Ballanger P; Lamarche P
    Ann Urol (Paris); 1985; 19(3):203-6. PubMed ID: 4040729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostatic osteocondensing metastases and osteomalacia. Value of histomorphometric study. Preliminary results].
    Coindre JM; Mage P; Bui BN; Goussot JF; De Mascarel I; De Mascarel A; Trojani M
    Presse Med; 1985 Oct; 14(35):1823-7. PubMed ID: 2933667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vitamin-sensitive osteomalacia in condensing bone metastases of prostatic origin. Apropos of 2 cases].
    Charhon S; Rouillat M; Bouvier M; Meunier PJ; Lejeune E
    Rev Rhum Mal Osteoartic; 1981 Jun; 48(6):469-76. PubMed ID: 7256162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A man with osteoblastic metastasis and hypocalcaemia.
    Lim SC; Tan CE; Aw TC; Khoo D; Eng P; Ho SC; Tai ES; Fok A
    Singapore Med J; 2000 Feb; 41(2):74-6. PubMed ID: 11063207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteomalacia associated with prostatic cancer and osteoblastic metastases.
    Kabadi UM
    Urology; 1983 Jan; 21(1):65-7. PubMed ID: 6687413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Dense bone metastases and hypophosphatemic osteomalacia during the course of prostatic cancer (author's transl)].
    Quilichini R; Aubert L; Chauvin M; Chaffanjon P; Eisinger J
    Sem Hop; 1979 Dec 18-25; 55(43-44):2037-9. PubMed ID: 233449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone metastasis with osteomalacia in cancer of the prostate. 2 cases].
    Delbarre F; Ghozlan R; Amor B
    Nouv Presse Med; 1975 Apr; 4(17):1277-8. PubMed ID: 168553
    [No Abstract]   [Full Text] [Related]  

  • 8. Sclerotic bone metastases of prostatic origin and osteomalacia. Importance of a histomorphometry study.
    Bürki F; Coindre JM; Mauriac L
    Prog Clin Biol Res; 1987; 243A():569-71. PubMed ID: 3659014
    [No Abstract]   [Full Text] [Related]  

  • 9. Distinction between focally accelerated bone formation and osteomalacia in carcinoma of prostate metastasised to bone.
    Taube T; Beneton MN; Williams JL; McCloskey EV; Kanis JA
    Br J Urol; 1993 Jul; 72(1):98-103. PubMed ID: 8149187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Osteomalacia in the metastatic region of prostatic origin resistant to vitamin and calcium therapy. Role of hypomagnesemia].
    Le Loët X; Ducastelle C; Hemet J; Deshayes P
    Rev Rhum Mal Osteoartic; 1983 Feb; 50(2):141-4. PubMed ID: 6857127
    [No Abstract]   [Full Text] [Related]  

  • 11. Histomorphometric analysis of sclerotic bone metastases from prostatic carcinoma special reference to osteomalacia.
    Charhon SA; Chapuy MC; Delvin EE; Valentin-Opran A; Edouard CM; Meunier PJ
    Cancer; 1983 Mar; 51(5):918-24. PubMed ID: 6681595
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of tumor-induced osteomalacia on the bone mineralization process.
    Nawrot-Wawrzyniak K; Varga F; Nader A; Roschger P; Sieghart S; Zwettler E; Roetzer KM; Lang S; Weinkamer R; Klaushofer K; Fratzl-Zelman N
    Calcif Tissue Int; 2009 Apr; 84(4):313-23. PubMed ID: 19219382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological and histological profile of osteomalacia in condensing prostatic osteosis. Apropos of 4 cases].
    Franck JL; Bouteiller G; Fauchier C; Sarramon JP; Arlet J
    Rev Rhum Mal Osteoartic; 1982 Feb; 49(2):81-5. PubMed ID: 6801753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Oncogenic osteomalacia: its pathogenesis, clinical picture and treatment].
    Ermolenko VM; Melikaian AM; Shotemor ShSh; Potapova AV
    Ter Arkh; 1995; 67(5):58-61. PubMed ID: 7638783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Biphosphonates in the treatment of bone metastasis of prostatic cancer].
    Paule B; Cicco A
    Prog Urol; 2001 Dec; 11(6):1205-12. PubMed ID: 11859653
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum alkaline phosphatase flare in prostate cancer accompanied by bone metastases and treated with hormonal therapy. TEKK Study Group].
    Taue R; Kanayama H; Kagawa S
    Hinyokika Kiyo; 1999 Oct; 45(10):681-5. PubMed ID: 10586358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of bone turnover for the management of patients with bone metastases from prostate cancer.
    Garnero P; Buchs N; Zekri J; Rizzoli R; Coleman RE; Delmas PD
    Br J Cancer; 2000 Feb; 82(4):858-64. PubMed ID: 10732759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey of spine surgeons on attitudes regarding osteoporosis and osteomalacia screening and treatment for fractures, fusion surgery, and pseudoarthrosis.
    Dipaola CP; Bible JE; Biswas D; Dipaola M; Grauer JN; Rechtine GR
    Spine J; 2009 Jul; 9(7):537-44. PubMed ID: 19328744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Osteomalacia in prostatic condensing osteosis with normal levels of 1-25 OH2 D3].
    Bouvier M; Bonvoisin B; Paupert-Ravault A; Lejeune E
    Nouv Presse Med; 1981 Nov; 10(42):3493-4. PubMed ID: 6895551
    [No Abstract]   [Full Text] [Related]  

  • 20. Oncogenic osteomalacia: muscular weakness and multiple fractures.
    Ladha SS; Whitaker MD; Bosch EP
    Neurology; 2006 Jul; 67(2):364-5. PubMed ID: 16864847
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.